Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Bottlenose dolphin communication during a role-specialized group foraging task.

Autor: Hamilton RA; School of Health Sciences, University of Manchester, Manchester, UK; Department of Biology, University of Massachusetts Dartmouth, MA, USA. Electronic address: rebecca.hamilton-5@postgrad.manchester.ac.uk., Gazda SK; Department of Biology, University of Florida, FL, USA., King SL; School of Biological Sciences, University of Bristol, Bristol BS8 1TQ, UK., Starkhammar J; Department of Biomedical Engineering, Lund University, Lund, Sweden., Connor RC; Institute of Environment, Florida International University, FL, USA; Department of Biology, University of Massachusetts Dartmouth, MA, USA.

Publikováno v: Behavioural processes [Behav Processes] 2022 Aug; Vol. 200, pp. 104691. Date of Electronic Publication: 2022 Jun 21.

A real-time medical cartography of epidemic disease (Nodding syndrome) using village-based lay mHealth reporters.

Autor: Valdes Angues R; Department of Neurology, Oregon Health & Science University, Portland, Oregon, United States of America., Suits A; University of Washington, Seattle, Washington, United States of America., Palmer VS; Department of Neurology, Oregon Health & Science University, Portland, Oregon, United States of America., Okot C; Hope for Humans, Gulu, Uganda., Okot RA; Hope for Humans, Gulu, Uganda., Atonywalo C; Awere Health Center III, Pader, Uganda., Gazda SK; Hope for Humans, Gulu, Uganda., Kitara DL; School of Medicine, Gulu University, Gulu, Uganda., Lantum M; MicroClinic Technologies, Ltd, Nairobi, Kenya., Spencer PS; Department of Neurology, Oregon Health & Science University, Portland, Oregon, United States of America.

Publikováno v: PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2018 Jun 15; Vol. 12 (6), pp. e0006588. Date of Electronic Publication: 2018 Jun 15 (Print Publication: 2018).

Alemtuzumab more effective than interferon β-1a at 5-year follow-up of CAMMS223 clinical trial.

Autor: Coles AJ; Department of Neurosciences, University of Cambridge, Addenbrooke’s Hospital, Cambridge UK. ajc1020@medschl.cam.ac.uk, Fox E, Vladic A, Gazda SK, Brinar V, Selmaj KW, Skoromets A, Stolyarov I, Bass A, Sullivan H, Margolin DH, Lake SL, Moran S, Palmer J, Smith MS, Compston DA

Publikováno v: Neurology [Neurology] 2012 Apr 03; Vol. 78 (14), pp. 1069-78. Date of Electronic Publication: 2012 Mar 21.

Alemtuzumab versus interferon β-1a in early relapsing-remitting multiple sclerosis: post-hoc and subset analyses of clinical efficacy outcomes.

Autor: Coles AJ; Department of Neurosciences, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. ajc1020@medschl.cam.ac.uk, Fox E, Vladic A, Gazda SK, Brinar V, Selmaj KW, Bass AD, Wynn DR, Margolin DH, Lake SL, Moran S, Palmer J, Smith MS, Compston DA

Publikováno v: The Lancet. Neurology [Lancet Neurol] 2011 Apr; Vol. 10 (4), pp. 338-48.